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Abstract
Glycerophosphoinositol is produced through deacylation of the essential
phospholipid phosphatidylinositol. In Saccharomyces cerevisiae, when inositol is limiting
in the extracellular environment, the glycerophosphoinositol can be transported into the
cell through the permease encoded by GIT1. In this study, Northern blotting and GIT1
promoter activity were analyzed to assess the nutritional factors responsible for the
regulation of GIT1 transcription. Here, I report that GIT1 transcript levels are greater in
cells starved for phosphate, with or without inositol limitation, than in cells only limited
for inositol. Ino2p and Ino4p are required for full GIT1 expression when the medium
lacks both inositol and phosphate. Pho2p and Pho4p are required for GIT1 expression
under all growth conditions tested. A 300 base pair region of the GIT1 promoter
containing potential Pho4p binding sites is shown to be required for full GIT1 expression.
Phd1p and Sok2p do not appear to be involved in the transcriptional regulation of GIT1
in response to inositol and phosphate limitation. Finally, my study revealed that
glycerophosphoinositol can act as the cell’s sole source of phosphate.
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Introduction
Yeast as a Model System
Baker’s yeast, Saccharomyces cerevisiae, has long been the eukaryotic model
organism of choice for studies of basic cellular processes. It was the first eukaryote to
have its genome fully sequenced(1). It is a useful reference against which sequences of
human, animal or plant genes, and those of a multitude of unicellular organisms, can be
compared.
Among all eukaryotic model organisms, S. cerevisiae has several advantages. It is
a unicellular organism and has powerful and welldeveloped molecular genetics, well-characterized
biochemistry, and is easily cultivated (1,2). It has
oblate

spheroid

or

ovoid

shaped

cells

approximately 3 µm in diameter (Figure 1). Under
optimal nutritional conditions, they can double
their mass every 1.5 to 2 hours at 300C (3). The
Figure 1. Budding Saccharomyces
cerevisiae cell.

genetic manipulation of S. cerevisiae is easy and

inexpensive, whereas such manipulation, when possible in mammalian systems, is neither
easy nor inexpensive (4). S. cerevisiae can be grown on defined media giving the
researcher complete control over environmental parameters (1).
The life cycle of S. cerevisiae normally alternates between a haploid state and a
diploid state (Figure 2). Haploid cells are of two mating types, a and α. Fusion of a and α
cells yields a/α diploid cells, which, under satisfactory nutritional conditions, will grow
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and divide, maintaining the diploid state (3). Under conditions of nutritional deficiency,

Figure 2. Life cycle of S. cerevisiae.

however, the diploid cells undergo meiosis to yield four progeny haploid cells, which
become encapsulated as spores within the wall of the mother cell (the ascus) (3). Upon
rupture of the ascus, the spores are released and subsequently germinate to commence
new rounds of haploid existence (Figure 2) (3). The haploid state allows for easy
recovery of recessive mutations. The diploid state allows facile genetic analysis,
including tests of complementation, recombination and epistasis (5). The replication
origin sequence allows plasmids to be maintained as free episomes, and these are easily
introduced into the cell by transformation. In addition, S. cerevisiae has high rates of
homologous recombination, allowing precise manipulation of the genome for the
construction of gene disruptions and allele-specific replacements (5).
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The genome of the yeast S. cerevisiae has been completely sequenced through a
worldwide collaboration (1). The genome of S. cerevisiae is divided into 16
chromosomes ranging in size between 250 kb and 2500 kb (1,6). With its 12 Mb of DNA,
the yeast genome is about 200 times smaller than the human genome, but less than four
times bigger than that of E. coli. At the onset of the sequencing project, knowledge about
some 1200 genes encoding either RNA or protein products had been accumulated (7).
The complete genome sequence defines some 6000 open reading frames (ORFs), most of
which are likely to encode specific proteins in the yeast cell (6). This means that a
protein-encoding gene is found for every 2 kb of the yeast genome, with almost 70% of
the total sequence consisting of ORFs (1,8). In addition to the protein-encoding genes, the
yeast genome contains 140 ribosomal RNA genes in a large tandem array on
chromosome XII, 40 genes encoding small nuclear RNAs (snRNAs), and 275 transfer
RNA (tRNA) genes (belonging to 42 families) which are widely distributed (1). Only
about 4% of the genes in S. cerevisiae have introns, which is much fewer than any other
eukaryote (1,2).
A number of experimental resources are available to yeast researchers. A
complete set of single gene deletions strains is commercially available. A large number of
strains carrying useful auxotrophic markers and drug resistance markers are available
commercially and from other researchers. Yeast gene expression can be assessed
indirectly by fusing the promoter region to a reporter gene. In yeast, two types of genes
have been used as reporter genes, endogenous genes like phosphoglycerate kinase (9),
and exogenous coding sequences such as lacZ (10-12), or certain bacterial resistance
genes, such as the cat gene (13).
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A large number of protocols for genetic manipulation in yeast are available
(14,15). High efficiency transformation of yeast cells is achieved, for example, by the
lithium acetate procedure (16). Many vectors have been designed to introduce and to
maintain or express recombinant DNA in yeast cells (14,15).
Finally, yeast is an excellent model organism because many important cellular
processes of higher eukaryotes are conserved in yeast. Those processes include DNA
replication, RNA synthesis. For these reasons, we have studied phospholipids metabolism
in S. cerevisiae.

Transcriptional Regulation in S. cerevisiae
Each cell is the product of specific gene expression programs involving regulated
transcription of thousands of genes (17). These transcriptional programs are modified as
cells progress through the cell cycle, in response to changes in environment, and during
organism development (17,18). Gene expression programs depend on recognition of
specific promoter sequences by transcriptional regulatory proteins (17,19). Those
regulatory proteins, or transcription factors, can bind to the DNA molecule and increase
or decrease the binding of RNA polymerases to the DNA molecule during the process of
transcription (20).
Lee et al. (17)

have identified six regulatory network motifs according to

systematic genome-wide location analysis for yeast transcription regulators. Young et al.
developed the genome-wide location analysis method, which allows protein-DNA
interaction to be monitored across the entire yeast genome (21). The method combined a
modified Chromatin Immunoprecitation (ChIP) procedure, which has been previously
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used to study in vivo protein-DNA interactions at one or a small number of specific DNA
sites (22), with DNA microarray analysis(21).

Figure 3. The genome-wide location analysis method. a, Formaldehyde crosslinking cells; b, Harvest
cells and fragment DNA; c, Enrich for regulator-bound DNA fragments; d, Differentially label
enriched & unenriched DNA; e, Hybridize to array. Modified from (21).

Cells, in which yeast transcriptional regulators were tagged by a c-myc epitope tag (106
different strains) (17), were fixed with formaldehyde (Figure 3a), isolated DNA was
fragmented by sonication (Figure 3b), and DNA fragments that were crosslinked to the
tagged transcriptional regulators were enriched by immunoprecipitation with a specific
antibody of c-myc epitope (Figure 3c) (21). After reversal of the crosslinking, the
enriched DNA was amplified and labeled with a fluorescent dye using ligation-mediated
PCR (LM-PCR) (21). A sample of DNA that has not been enriched by
immunoprecipitation is subjected to LM-PCR in the presence of a different fluorophore
(Figure 3d), and both immunoprecipitation-enriched and unenriched pools of labeled
DNA were hybridized to a single DNA microarray containing a genome-wide set of yeast
promoter regions (Figure 3e)(21).
From this experiment, the authors proposed six regulatory motifs (Figure 4) (17).
An autoregulation motif consists of a regulator that binds to the promoter region of its
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own gene and provides selective growth advantages. A multicomponent loop consists of
a regulatory circuit whose closure involves two or more factors and provides the capacity
for feedback control and offers the potential to produce bistable systems that can switch
between two alternative states (23). Feedforward loop motifs contain a regulator that

Figure 4. Examples of network motifs in the yeast regulatory network. Regulators are
represented by light blue circles; gene promoters are represented by pink rectangles. Binding of a
regulator to a promoter is indicated by a solid arrow. Genes encoding regulators are linked to
their respective regulators by dashed arrows. Modified from (21).

controls a second regulator and have the additional feature that both regulators bind a
common target gene. Single-input motifs contain a single regulator that binds a set of
genes under a specific condition. Multi-input motifs consist of a set of regulators the bind
together to a set of genes and offers the potential for coordinating gene expression across
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a wide variety of growth conditions; and Regulator chain motifs consist of chains of three
or more regulators in which one regulator binds the promoter for a second regulator, the
second binds the promoter for a third regulator, and so forth (17). These regulatory motifs
suggest models for gene regulatory mechanisms whose predictions can be tested (17).
A complete understanding of transcriptional regulatory networks in yeast requires
knowledge of regulator binding sites under various growth conditions (17). Since inositol
and phosphate are required for the survival of all eukaryotic cells, these nutrients are
expected to regulate the transcription of a network of genes involved in their metabolism
(24).

Phospholipids Metabolism in S. cerevisiae
The plasma and intracellular membranes of S. cerevisiae are composed of a
typical mixture of phospholipids. Membrane lipids have been implicated in vital cellular
processes such as proliferation and differentiation in multicellular eukaryotes (25).
Membrane phospholipids are involved in other functions pertaining to lipoprotein
metabolism (26,27), cell surface recognition (28), and aging of erythrocytes (29,30). In
addition, fluctuations in phospholipids synthesis are a manifestation of a number of
clinical problems, including Alzheimer’s disease (31), human immunodeficiency virus
type 1 cytotoxicity (32), cystic fibrosis (33), and poliovirus replication (34). Therefore,
phospholipid biosynthesis is an essential process of all eukaryotic cells and S. cerevisiae
is a good model for the study of phospholipids synthesis (25).
S. cerevisiae synthesize the inositol- and choline-containing phospholipids that
are typical of all eukaryotes, via pathways that are, for the most part, similar to those in
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other eukaryotes (2). Phosphatidic acid (PA) is the precursor of the major phospholipids
present in cell membranes (25). Another phospholipid precursor is inositol, which is a
key regulator of expression of enzymes involved in the synthesis of PA-derived lipids
(25). Cytidinediphosphate diacylglycerol (CDP-DG) is the liponucleotide intermediate
from which diverge the three branches of de novo phospholipid biosynthesis (Figure 5).
These include the phosphatidylinositol (PI), phosphatidylcholine (PC), and cardiolipin
(CL) (25).

Figure 5. Pathways of phospholipids biosynthesis and turnover in S. cerevisiae. C, choline; C-P,
choline-phosphate; CDP-C, cytidine diphosphate-choline; DAG, sn-1,2-diacylglycerol; CDP-DG,
cytidine-diphosphate diacylglycerol; FA, fatty acid; Glu-6-P, glucose-6-phosphate; Gly-3-P, glycerol3-phosphate; GPI, glycerophosphoinositol; I, inositol; I-1-P, L-myoinositol 1-phosphate; INO1, gene
encoding the inositol-1-phosphate synthase; PA, phosphatidic acid; PC, phosphatidylcholine; PE,
phosphatidylethanolamine,
PG,
phosphatidylglycerol;
PI,
phosphatidylinositol;
PIP,
phosphatidylinositol phosphate; PIP2, phosphatidylinositol biphosphate; PS, phosphatidylserine.
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PI is an essential component of the yeast membrane. It can be synthesized directly
from exogenous inositol or de novo from glucose-6-phosphate (35). INO1 and PIS1, two
structural genes, are required for the de novo synthesis of PI from glucose-6-phospate.
The INO1 gene encodes the soluble inositol-1-phosphate synthase (IPS) (36,37), which
catalyzes the conversion of glucose-6-phosphate to inositol-1-phosphate. Inositol-1phosphate is subsequently dephosphorylated to inositol (38,39). The membraneassociated PIS1gene product, PI synthase (PIS), converts inositol and CDP-DG to PI
(40,41). CDP-DG also reacts with serine to form PS in a reaction catalyzed by the
membrane-associate enzyme phosphatidylserine synthase (42). PS is subsequently
decarboxylated, yielding PE, which
then undergoes three sequential
methylations, culminating in the
formation of PC (42).
PI can also be deacylated to
form

extracellular

glycerophosphoinositol
Phospholipid

(GPI).

deacylation

(the

removal of the fatty acid chains) can
occur
Figure 6. Deacylation of PI to GPI.

via

phospholipases

the
B

activity

of

(PLB’s),

phospholipases A (PLA’s), and other lysophospholipases (Figure 6) (2,43). PLB’s, three
of which have been identified in yeast, hydrolyze both fatty acid chains of a phospholipid
to produce a glycerophosphodiester, such as glycerophosphoinositol (GPI). The
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generation of extracellular GPI through PI deacylation is a major catabolic pathway in S.
cerevisiae, accounting for approximately 50% of the phosphorous and inositol lost from
PI during growth in rich medium (43). The production of extracellular GPI is regulated
by both glucose and inositol (44,45) and is postulated to be the result of the activity of
cell surface phospholipases localized in the plasma membrane and/or periplasmic space
(45,46).
S. cerevisiae not only releases GPI into the medium, but is also capable of
transporting GPI back into the cell through the product of the GIT1 gene (Figure 7), a

Figure 7. Glycerophosphoinositol metabolism in S. cerevisiae. Gly-3-P, glycerol-3-phosphate; GPI,
glycerophosphoinositol; I, inositol; PI, phosphatidylinositol; PIS, phosphatidylinositol synthase; PLB,
phospholipase.

permease containing 12 membrane spanning regions and a sugar transport motif. When
inositol is limiting, GPI is transported into the cell, where it is catabolized and its inositol
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portion used for the synthesis of PI (44). In addition to the GPI production observed in
logarithmically growing cells of S. cerevisiae, the addition of glucose to glucose-starved
cells stimulates the immediate production of PI-3-P (phosphatidylinositol-3-phosphate),
PI-4-P(phosphatidylinositol-4-phosphate), and PI-4, 5-P2 (phosphatidylinositol 4, 5bisphosphate)

(47)

followed

by

(glycerophosphoinositol-4-phosphate),

the

extracellular

release

of

GPI,

GPI-4-P

and GPI-4,5-P2 (glycerophosphoinositol-4,5-

bisphosphate) (47). This suggests that the nutrient signal of glucose re-feeding activates
one or more phospholipases and/or lysophospholipase which deacylate the respective
phosphoinositides.

Transcriptional Control of Phospholipid Biosynthesis
Inositol limitation in S. cerevisiae results in the coordinate induction of a set of
genes involved in phospholipid biosynthesis. The most highly regulated of these is INO1,
the gene encoding inositol-1-phosphate (I1P) synthase, the enzyme that catalyzes the
rate-limiting step in the synthesis of inositol (2,48). The native INO1 transcript shows 30fold or more derepression (2). Upon inositol limitation, inositol-1-phosphate synthease is
a tetramer composed of identical subunits of 62,000 Daltons, which are the product of the
INO1 gene (42,49). Computer-assisted analysis of the 5’ region of the INO1 gene
revealed seven copies of a nine-bp element or nonamer (consensus:ATGTGAAAT) in the
INO1 promoter (50,51). The nonamer is also present in multiple copies in the promoters
of other coregulated genes (52). INO1 is the most tightly controlled of the coregulated
genes, displaying up to 30-fold repression in cells grown in the presence of the soluble
precursors, inositol and choline (2,53). The coregulated genes all contain UASINO
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(inositol upstream activation sequences). The consensus sequence for the element
(5’CATGTGAAAT3’) contains within it the core binding site (CANNTG) for DNA
binding proteins of the basic helix-loop-helix (bHLH) class (54). Other genes regulated
by inositol are involved in phosphatidylcholine biosynthesis, including CHO1, CHO2,
CKI1 (2).
The INO2 and INO4 are transcription factors required for derepression of
phospholipid biosynthetic gene expression in response to inositol deprivation (54).
Strains containing mutations in either of these two genes are unable to derepress
transcription of the INO1 and CHO1 (25,54), phospholipid biosynthetic genes when cells
are grown in the absence of inositol. The inability to derepress expression of the INO1
gene results in the characteristic inositol auxotrophy which is the hallmark of ino2∆ and
ino4∆ mutant strains (25,54). The products of the INO2 and INO4 genes have been
shown to heterodimerize and interact with a conserved UASINO (55,56). While INO2
gene expression is down regulated ~12-fold by inositol and choline in a manner similar to
that of its target genes (57), INO4 expression is only modestly regulated by inositol and
choline at the post-transcriptional level (58).
The OPI1 (overproduction of inositol) gene encodes a negative regulator of
phospholipid biosynthesis (59). The opi1 mutants exhibit two-fold constitutive
overexpression of I1P synthase and other coregulated phospholipids biosynthetic
enzymes (50,60). OPI1 gene lies on chromosome VIII (59). OPI1 encodes a protein of
404 amino acids (OPI1p) with a predicted molecular weight of 40,036 (50). Opi1p has
two features that are all hallmarks of transcriptional regulatory proteins, namely, a
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leucine zipper and glutamine-rich regions (25,59). However, binding of OPI1 to DNA
has never been shown.

Transcriptional Control of Phosphate Metabolism
Starvation for phosphate (Pi) in S. cerevisiae results in the coordinated induction
of a set of phosphatase genes (PHO5, PHO10, and PHO11) and the structural gene for
low-Km Pi transport, PHO84 (24,61,62). The transcriptional status of PHO5, a gene
whose product supplies more than 90% of the acid phosphatase activity, is typically used
as a marker for the entire phosphate (PHO) system (61). The PHO system is comprised of
five regulatory genes: PHO2, PHO4, PHO80, PHO81, and PHO85.The induction of
PHO gene transcription during phosphate starvation is mediated by Pho4p, a bHLH
transcription factor, and Pho2p, a homeobox DNA binding protein (24). Pho4p binds to
two bHLH consensus sequences (CANNTG) in the PHO5 promoter, and Pho2p binds
cooperatively with Pho4p (24,63). The ability of Pho4p to function as a transcriptional
activator depends on its phosphorylation state (54). When cells are grown in the presence
of high concentrations of inorganic phosphate, Pho4p is hyper-phosphorylated (54,64).
Pho80p and Pho85p form a kinase complex, similar to that formed by a cyclin and a
cyclin-dependent protein kinase, which hyperphosphorylates and inhibits Pho4p function,
thereby blocking PHO5 transcription (65). As inorganic phosphate becomes limiting,
Pho4p becomes de-phosphorylated. The de-phosphorylated Pho4p is transported back
into the nucleus by the import protein Pse1p (54). Also, Pho81p inhibits the Pho80pPho85p complex and allows the transcription of PHO5 (24,66).
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PHO5, and the other repressible acid phosphatase (rAPase) enzymes, are
constitutively expressed in strains bearing mutations in PHO84, the low Km Pi transporter
gene. Impaired Pi transport also results in resistance to the growth inhibiting Pi analog
arsenate. Other genes thought to be involved in Pi transport include PHO87, PHO88,
PHO89, PHO90 and PHO91 (24,67). Pho86p is an endoplasmic reticulum protein that is
required for the transport of Pho84p to the plasma membrane (24,68). Strains bearing
mutations in PHO86 show constitutive rAPase activity and reduced Pi transport (24).

GIT1 Gene
PI catabolism in S. cerevisiae cells cultured in media containing inositol results in
the release of GPI into the medium. As the extracellular concentration of inositol
decreases with growth, the released GPI is transported back into the cell (46). GIT1
(glycerophosphoinositol) is a gene encoding a transporter for glycerophosphoinositol in S.
cerevisiae (46).
The GIT1 gene is located on the right arm of chromosome III, 18kb from the
telomere and 4 kb from the HMR, a silent mating type loci. The open reading frame
(ORF) consists of 1556 bp predicted to encode a polypeptide of 518 amino acids and
57.3kD (46). A Kyte and Doolittle (69) hydropathy profile of the deduced amino acid
sequence (70) indicates the presence of 12 potential membrane-spanning regions and
hydrophilic N and C termini. A sugar transport motif [SDRIGR(K/R)(4-5)G] at amino
acid 329 was also identified (70). An analysis of the GIT1 promoter region revealed that
three potential Pho4p binding sites and two potential Pho2p binding sites exist in the
GIT1 promoter region between nucleotides -1 and -700, relative to the ATG start codon
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(71). Within the S. cerevisiae genome, GIT1 bears similarity to a number of other
metabolite transporters including the inorganic phosphate transporter, PHO84, and the
inositol transporters, ITR1 and ITR2 (46).

Regulation of GIT1 Transcription and Git1p Transport
S. cerevisiae not only produces but also reutilizes extracellular GPI and these
processes are regulated in response to inositol availability (44). A wild-type strain
uniformly prelabeled with [3H] inositol displays dramatically higher extracellular GPI
levels when cultured in medium containing inositol than when cultured in medium
lacking inositol (44,46). GPI is transported back into the cell through the action of the
Git1p permease (46). This difference in extracellular accumulation of GPI in response to
inositol availability is a result of both regulated production and regulated reutilization
(44).
A genetic screen identified Pho86p, which is required for targeting of the major
phosphate transporter Pho84p to the plasma membrane, as affecting the utilization of
phosphatidylinositol and glycerophosphoinositol (46). An ino1∆pho86∆ mutant utilizes
GPI and PI as inositol sources more efficiently than an ino1∆ strain. This result, and
others, suggested that the PHO86 gene product and phosphate concentration affect GIT1
transcription and transport. Because both inositol and phosphate affect GIT1 transcription,
the transcription factors INO2, INO4, PHO2, and PHO4 are likely candidates for
regulating GIT1 transcription.
Young (21) et al. suggested that Sok2p and Phd1p, transcription factors involved
in the nitrogen limitation response, may also affect GIT1 transcription. Young (21) et al.
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performed genome wide chromatin-IP and reported that Sok2, Phd1 were bound to the
GIT1 promoter. Nitrogen limitation stimulates diploid cells of S. cerevisiae to undergo a
dimorphic transition to a filamentous growth form referred to as pseudohyphal
differentiation (72,73). Sok2p and Phd1p are the transcription factors known to regulate
filamentous growth (72). Sok2p contains a basic helix-loop-helix motif that is highly
conserved among a family of transcription factors that regulate fungal cell cycle
progression and morphogenesis (72). It was originally identified as a suppressor of
temperature-sensitive PKA mutation (74) and negatively regulates pseudohyphal
differentiation (75). Phd1p is a second transcription factor with a highly conserved helixloop-helix motif that is related to Sok2p and other transcription factors (81).
Overexpression of the PHD1 gene increases pseudohyphal growth even on nitrogen-rich
medium (76). The sok2∆/sok2∆ mutant strains undergo pseudohyphal differentiation on
nitrogen-rich medium, and cells in these filaments are very long (72). Sok2p regulates
pseudohyphal differentiation via a complex cascade of transcription factors including
Phd1p (72).

The Specific Aims
The goals of the work presented here are the following:
1)

Examine the role of phosphate and inositol availability in regulating GIT1

transcription.
2)

Examine the role of the transcription factors Ino2p, Ino4p, Pho2p, Pho4p, Opi1p,

Sok2p, and Phd1p in regulating GIT1 transcription.
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3)

Determine the regions of the GIT1 promoter that are important for regulation by

inositol and phosphate.
4)

Examine the ability of GPI to act as a phosphate source.
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Materials and Methods
Strain and Media
The strains used in this study are listed in Table 1. JPV134 and JPV136 were
crossed to make JPV381. Strains were grown aerobically at 300C with shaking. Turbidity
was monitored by measurement at A600 with a Biomate 3 Thermo Spectronic
spectrophotometer. Synthetic complete medium was prepared as described previously
(44) (Appendix 1). “High Pi”, “Low Pi”, and “no Pi” media, were made by replacing the
KH2PO4 (1gm/liter) in synthetic complete medium with KCl (1gm/liter) and adding
KH2PO4 to 10 mM (high Pi), 0.2 mM (low Pi), or no KH2PO4 (no Pi). Where indicated,
media lacked inositol (-I), contained 5 µM inositol (5 I-), or contained 75µM inositol (+I).
Media may also have been supplemented with GPI (Sigma). YPD media consisted of 20
g glucose, 10 g yeast extract, and 20 g bacto peptone per liter.

Northern Analysis
Wild-type cells (JPV203), ino2∆(JPV339), ino4∆(JPV340), pho2∆(JPV295), and
pho4∆(JPV296) pregrown in + I, high-Pi medium were used to inoculate each of the
following media: - I, low Pi; + I, low Pi; - I, high Pi; and + I, high Pi. Cells were
harvested in the logarithmic phase.
RNA was extracted using the hot acid phenol method (77). Cells were suspended
in 400 µl of TES (10 mM Tris.CL, pH 7.5, 10 mM EDTA, 0.5% SDS) solution and 400
µl of acid phenol. Then, cells were incubated 60 min at 650C with occasionally vortexing.
The cells were placed on ice for 5 min, and centrifuged 5 min at top speed. The aqueous
phase was transferred to a clean 1.5 ml microcentrifuge tube, 400 µl of acid phenol was
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added and the sample was vortexed. The sample was centrifuged again. The aqueous
phase was collected and 400 µl of chloroform was added. The sample was vortexed and
centrifuged. The aqueous phase, 3 M sodium acetate (pH 5.3, 40 µl/tube), and ice-cold
100% ethanol were mixed and nucleic acids were precipitated. The RNA pellet was
washed with 70% ethanol and resuspended in 50 µl of DEPC (diethylpyrocarbonate)
H2O. The concentration of RNA was monitored by measurement of the A600 with a
Biomate 3 Thermo Spectronic spectrophotometer.
Table 1.
Yeast Strains

Strain
WT
(JPV203)
WT
(JPV134)
WT
(JPV136)
WT
(JPV381)
ino2∆
(JPV339)
ino4∆
(JPV340)
pho2∆
(JPV295)
pho4∆
(JPV296)
git1∆
(JPV212)
opi1∆
(JPV342)
sok2∆/sok2∆

(JPV358)

phd1∆/phd1∆

(JPV360)

Genotype
his3 1, leu2 0, met15 0, ura3 0, MATa
his3, leu2, ura3, met15, MATa
his3, leu2, ura3, lys2, MATα
a/α, his3/his3, leu2/leu2, ura3/ura3,
MET15/met15, LYS2/lys2
his3 1, leu2 0, met15 0, ura3 0, ino2::KanMX,
MATa
his3 1, leu2 0, met15 0, ura3 0, ino4::KanMX,
MATa
his3 1, leu2 0, met15 0, ura3 0, pho2:kanMX,
MATa
his3 1, leu2 0, met15 0, ura3 0, pho4:KanMX,
MATa
his3 1, leu2 0 lys2 0 ura3 0 git1 ::KanMX,
MATa
BY4741 Research Genetics with opi1::KanMX
ahis3∆1,leu2∆0,met15∆0,ura3∆0/αhis3∆0,leu2∆0,
lys2∆0,ura3∆0 sok2D/sok2D
ahis3∆1,leu2∆0,met15∆0,ura3∆0/αhis3∆0,leu2∆0,
lys2∆0,ura3∆0 phd1∆/phd1∆

Source
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
This study
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
Research Genetics
Inc.
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RNA was separated on a 1% agarose gel in 1x MOPS (morpholino-propane
sulphonate) buffer containing 2 ml of 37% formaldehyde. 20 µg of RNA was loaded into
every well. The gels were subjected to electrophoresis in 1x MOPC buffer at ~50 volts
(24).
RNA was transferred to a positively charged nylon membrane (Roche
Biochemical) by blotting, and UV crosslinked to the membrane using a Stratalinker.
Digoxigenin (DIG)-labeled probes for GIT1 and control (SNR17) transcripts were made
by using a Roche PCR DIG probe synthesis kit (catalog no. 1-636-0900). The nylon
membrane was prehybridized using Dig Easy Hyb (Roche Biochemical) at 500C, and
then hybridized to the denatured probe solution overnight. The membrane was washed
with DIG Wash and Bock Buffer set (Roche Biochemical) and incubated with AntiDigoxigenin-AP (Roche Biochemical).

Finally, the detection was performed in

accordance with the manufacture’s instructions for a Roche DIG luminescence detection
kit (Roche Biochemical).

Chloramphenicol Acetyltransferase (CAT) Assays
Strains with plasmid of pCA999, pWC639, or pWC335, pregrown in + I, high Pi,
leu- medium were harvested and used to inoculate the following media: 1) - I, low Pi, leu; 2) + I, low Pi, - leu; 3) - I, high Pi, - leu; 4) +I, high Pi, - leu. For the inositol
auxotrophs, ino2∆ and ino4∆, 5I- media was substituted for – I media. At the indicated
times, aliquots of the cultures were harvested. YPER (yeast protein extraction reagent)
200 µl was added to the cell pellet and vortexed. The mixture was centrifuged and the
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supernatant was collected. The total protein concentration of each lysate was determined
with bicinchoninic acid reagent (78).
CAT activity was performed in accordance with the manufacturer’s protocol for a
FAST CAT green (deoxy) CAT assay kit (molecular Probes catalog no. F-6616) (24). A
60 µl of YPER was used as a negative control, while the mixture of 59 µl of YPER and
1µl of purified CAT enzyme was an appropriate positive control. There were 30 µg of
protein in each assay. For the assay, controls and 60 µl of cell extract with 10µl of FAST
CAT substrate solution were incubated at 370C for 5 minutes. A 10 µl of 9 mM acetyl
CoA was added to every assay, and the incubation was continued at 370C for 2.5 hours.
Ice-cold ethyl acetate 1 ml was added to stop the reaction. Each sample was vortexed for
20 seconds. The samples were centrifuged at top speed for 5 minutes to separate the
phases. The top 900 µl of ethyl acetate was removed and transferred into a clean tube.
The solvent was evaporated to dryness. The residue was dissolved in 20 µl - 30 µl of
ethyl acetate. A 5 µl of the FAST CAT reference standard solution and 10 µl of each
ethyl acetate extract were applied 1-2 cm above the bottom of a Silica gel-coated thinlayer chromatography plate. The plate was placed in a chromatography chamber that was
filled with 85 ml of chloroform and 15 ml of methanol. The chamber was sealed and the
solvent allowed to ascend the plate. The plate was removed and to dried in a hood. The
separated reaction products were analyzed using a Kodak Image Station 440 (24).

Sequencing (University of Pittsburgh)
Sequencing was performed at the University of Pittsburgh’s Center for
Biotechnology and Bioengineering. The following reaction mix was used to prepare
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samples for sequencing: 500 ng template DNA, 3.4 pmole of primer and sterile H2O to a
final volume of 13 µl. The samples were sent to the University of Pittsburgh DNA
Sequencing Core Facility to be sequenced.

Construction of GIT1-cat Fusion Plasmids
The bacterial chloramphenicol acetyltransferase (CAT) gene (cat) under the
control of the GIT1 promoter was inserted into vector YCp7-32cat (13) to produce
plasmid pCA998 (24). The following PCR primers (Gibco) were used to amplify the
GIT1 promoter (nucleotides -7 to -881 upstream of the start codon) and to introduce the
flanking

restriction

site:

SalI

forward

(5’-

TCGCCCATGGGGGTCGACTCGATATCTGCGATAAGG-3’) and BamHI reverese
(5’-TCGCCCATGGGGGGATCCTCCTATTCTATTTTTTT-3’). The PCR product and
YCp7-32cat were digested with BamHI and SalI and ligated together to form pCA998.
To produce a reporter construct with a LEU2 selectable marker, pCA998 was digested
with SalI and HindIII to release the 2.7-kb fragment in which the GIT1 promoter is fused
to the cat gene. The 2.7-kb fragment was ligated to pRS315 (79) to produce pCA999.
For the construction of plasmid pWC639 (Figure 8), a 2.4-kb fragment containing
a portion of the GIT1 promoter (nucleotides -7 to -639 upstream of the start codon) fused
to the CAT gene was amplified by PCR using pCA999 (24). Primers contained homology
to the pCA999 plasmid as well as sequences to introduce flanking restriction sites for SalI
(forward

primer:

5’-

ATCGCGAATGTCGACCGTTTTGCCAAGATAAATTAAAAAAAG-3’) and HindIII
(reverse

primer:

5’-
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TGGGTTGGAAGGCAAGAGAGCCCCGAAAGCTTAGTTACGATC-3’).

The PCR

product and plasmid pRS315 (79) were digested with SalI and HindIII and ligated to
produce pWC639.

Figure 8. Construction of pWC639 and pWC335.

pWC335 (Figure 8) is a 2.03-kb fragment (nucleotides -7 to -335 upstream of the
start codon). It was amplified by PCR using pCA999 (24) as a template. Primers
contained homology to pCA999 (24) as well as sequence to introduce flanking restriction
sites

for

SalI

(forward

primer:

5’-

ATCGCGAATGTCGACGGACCCCCACCTTAGCATGGATTGATT-3’) and HindIII
(TGGGTTGGAAGGCAAGAGAGCCCCGAAAGCTTAGTTACGATC-3’). The PCR
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product and plasmid pRS315 (79) were digested with SalI and HindIII and ligated to
produce pWC335 (71).

E. coli Electroporation
E. coli (JVE030) was grown in sterile LB-amp (500ml) at 370C with shaking.
Turbidity was monitored by measurement at A600 with a Biomate 3 Thermo Spectronic
spectrophotometer. Cells were collected in the logarithmic phase and placed on ice for 15
minutes. The cells were pelleted and then washed twice with ice cold water. Cells were
resuspended in 3 ml ice-cold water. The electroporator was set at 2500V. 400 µl cells
suspension and 1 µl ligation were transferred to pre-chilled 2 mm cuvettes, pulsed for
~5ms and 1ml of LB-amp was immediately added and vortexed gentlely. Then, the cells
were incubated with shaking at 370C for 30 minutes. Finally, the cells were plated onto
LB-amp plate at 370C.

Preparation of Plasmid DNA
All small-scale preparations of plasmid DNA were performed using Eppendorf’s
prefectprep plasmid Mini (Eppendorf).
All large-scale preparations of plasmid DNA were performed using the
recommended protocol included with either Promega’s Wizard Plus Midiprep DNA
Purification System (Promega A 7640) or QIAGEN Plasmid Maxi kit (QIAGEN 12162).
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PCR Purification
DNA was purified using the recommended protocol included with QIAGEN’s
QIAquick PCR Purification Kit.

Agarose Gel Electrophoresis
A 45 ml of 1x TAE Buffer (50x stock: pH 8.5, 242 g Tris base, 57.1 ml glacial
acetic acid, 37.2 g Na2EDTA•2H2O, H2O to 1 liter) was used to suspend 0.45 g of
agarose (Fisher Scientific DNA Grade) and the mixture was microwaved for 1.5 minutes
until the agarose was completely dissolved. After cooling, 1.5 µl of 10 mg/ml ethidium
bromide was added to the solution and mixed. Gel was electrophoresed in 1x TAE buffer
at 90 volts.

High Efficiency Transformation of Yeast
Yeast cells were grown in YPD (50 ml) at 300C with shaking. Turbidity was
monitored by measurement at A600 with a Biomate 3 Thermo Spectronic
spectrophotometer. Cells were collected in the logarithmic phase and washed with sterile
water once. Cells were suspended in 1 ml of 100 mM lithium acetate and pelleted by
centrifugation. The pellet was resuspended in 300-400 µl lithium acetate. To 50 µl of cell
suspension, was added 240 µl of PEG (50%w/v), 36 µl of 1.0 M lithiuim acetate, 5 µl of
single-stranded carrier DNA (10 mg/ml), and 50µl of water and plasmid DNA(0.1-10ug).
The solution was mixed and incubated at 300C for 30 minutes, and then heat shock at
420C for 25 minutes. The solution was centrifuged and the resulting pellet resuspended
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in 200 µl of water. A 20µl of the cell suspension was spread onto a plate lacking leucine
and incubated at 300C for 2 days.
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Results
Northern Analysis
The roles of the transcription factors Ino2p, Ino4p, Pho2p, and Pho4p in
regulating GIT1 transcription in response to inositol and phosphate availability were
investigated. WT, ino2∆, ino4∆, pho2∆, pho4∆, and git1∆ strains were grown to
logarithmic phase in ± I, low Pi, and ± I, high Pi media. When a wild-type strain was
grown in ± I, low Pi, it accumulated GIT1 transcript. Transcription appeared to be the
greatest when cells were grown in - I, low Pi (Figure 9). When cells were grown in ± I,
high Pi, no transcript was detected. The pho2∆, pho4∆, and git1∆ mutants accumulated
no detectable GIT1 transcript under any growth conditions. The inositol auxotrophs,
ino2∆ and ino4∆, were grown in 5 I - instead of - I media, a concentration of inositol that
does not fully repress the transcription of other genes known to be regulated by inositol
(48,71). Surprisingly, ino2∆ and ino4∆ mutants did not show any GIT1 transcript in the 5
I -, low Pi and - I, high Pi condition, but accumulated transcript in the + I, low Pi. Based
upon these results, PHO2 and PHO4 genes are necessary for GIT1 transcription.

Derepression of GIT1 Promoter Activity
Our inability to detect GIT1 transcript by Northern analysis (Figure 9) in cells
grown in - I, high Pi

medium, a condition which clearly supports Git1p mediated

transport (24,46), prompted us to perform a more in-depth analysis of GIT1 expression.
The strains were transformed with pCA999, a plasmid in which GIT1 promoter was fused
to the bacterial chloramphenicol acetyltransferase (CAT) gene (cat) (Figure 8) (24). By
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measuring CAT activity, the activity of the GIT1 promoter was monitored as a function
of time following the transfer of cells from + I, high Pi to various starvation media
(Figure 11).
CAT activity was measured by monitoring the intensities of the fluorescent
substrate, BODIPY FL I-deoxychloramphenicol substrate. The substrates and products
were separated by TLC plate and the intensity of the fluorescent spots were monitored
using the Kodak Image (Figure 10 A-E) (24).The wild type cells did not show any CAT
activity when they were grown in + I, high Pi medium. Transfer of wild type cells into - I,
high Pi medium resulted in a slight increase in CAT activity that reached a plateau after 3
hours. In contrast, transfer of wild type cells into low phosphate media (± I, low Pi)
caused an increase in CAT activity that continued to rise, even as the cells entered the
post-diauxic shift ( Figure 11a) (71).
The ino2∆ and ino4∆ mutants were grown in ± I, low Pi, and - I, high Pi. Both of
those strains grown in - I, low Pi and - I, high Pi showed a small increase in CAT activity.
In contrast, the ino2∆ and ino4∆ mutants grown in + I, low Pi exhibited CAT activity
similar to wild type cells grown in the same condition (Figure 11b, 11c).
The strain bearing a deletion in PHO2 produced little or no GIT promoter-driven
CAT activity under any growth condition (Figure 11d). The pho4∆ mutant showed
similar CAT activity as the pho2∆ mutant (data not shown).
These results demonstrate that Pho2p and Pho4p are required for the CAT activity
under any condition. Ino2p and Ino4p are required for the CAT activity under - I
conditions.
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GIT1 Promoter – driven CAT Activity and Opi1p, Phd1p and Sok2p
CAT activity was determined in logorithmic phase (OD 0.5 ~ 0.9) and stationary
phase (OD 1.4 ~ 1.9) for wild-type haploid, opi1∆, wild-type diploid, phd1∆ / phd1∆, and
sok2∆ /sok2∆ strains. For this study, diploid strains bearing homologous deletions were
employed, as the morphological phenotypes caused by deleting the genes are only seen in
the diploid state. The opi1∆ mutant was analyzed because it exerts negative regulation in
the phospholipids biosynthesis (25). phd1∆ / phd1∆, and sok2∆ /sok2∆ mutants were
analyzed because they were reported to be regulators of GIT1 (21). The strains were
grown initially in +I, high Pi, medium and then transferred to four different media which
varied in inositol and phosphate concentrations.
The CAT activity of wild-type haploid and diploid increased significantly in ± I,
low Pi, media. However, the increase in activity was much smaller in ± I, high Pi, media
(Table 2). This result is similar to the one obtained previously (Figure 11a).
In general, opi1∆ has the same pattern of regulation as a WT haploid strain (Table
2). The CAT activity of the strain bearing a deletion in OPI1 was not changed between
early and late times under four conditions. However, the CAT activity of opi1∆ was
slightly higher in low concentrations of phosphate than high. This result indicated that the
CAT activity of opi1∆ peaks early.
The CAT activity of phd1∆ / phd1∆ strain and sok2∆ / sok2∆ strain varied only
slightly from the activity seen in the wild type diploid strain. Because the examination of
GIT1 promoter – driven CAT activity in strains bearing deletions in OPI1, PHD1 and
SOK2 were performed only once, no definite conclusions can be drawn. However,
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because we saw no major change in GIT1 promoter-driven activity, work with these
mutants was abandoned.

Potential Transcription Factor Binding Sites
The PHO regulation transcription factor, Pho4p, is a bHLH binding protein whose
consensus sequence is CACGTK (62). Three potential Pho4p binding sites and two
potential Pho2p binding sites (TAATRA/TAANTAA) exist in the GIT1 promoter region
between nucleotides -1 and -700 relative to the ATG start codon (71). To identify the
regions of the promoter important for the role of phosphate metabolism in regulating
GIT1 transcription, a promoter deletion analysis was performed (Figure 12). GIT1
promoter-driven CAT activity was compared in cells harboring one of three plasmids:
pCA999 contains nucleotides -7 to -881 relative to the ATG start codon; pWC639
nucleotide -7 to -639; and plasmid pWC335 nucleotides -7 to -335 (Figure 12). A wild
type strain bearing each of the above plasmids was grown in the phosphate and inositol
limited medium. Removal of one potential Pho4p binding element (pWC639) resulted in
a 20-30% decrease in CAT activity in the - I, low Pi and + I, high Pi conditions. When all
three potential Pho4p binding elements were removed (pWC335), CAT activity was
deceased ~70% in low phosphate media, similar to the level of activity seen in the high Pi
media (Figure 12).
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Testing for Ability of Yeast to Use GPI (Glycerophoinositol) as Phosphate and
Inositol Source
The increase in GIT1 transcript upon phosphate starvation suggested that
Saccharomyces cerevisiae may utilize GPI as a source of phosphate. WT, git1∆, ino2∆,
ino4∆, pho2∆, and pho4∆ strains grown in low phosphate medium, were harvested,
washed, and spotted onto phosphate-free solid media, media containing 75 µM KH2PO4,
or media containing 75 µM GPI. WT type cells grew when GPI was provided as their
sole source of phosphate in a GIT1 dependent fashion (Figure 13). However, pho2∆ and
pho4∆ did not grow in the phosphate-free plates with GPI as phosphate source. This
result was expected, given that the pho2∆ and pho4∆ mutants displayed little or no GIT1
transcription (Figure 9 and 11).The inositol auxotrophs, ino2∆ and ino4∆, could grow in I
+ medium containing 75 µM KH2PO4, but not I - medium containing 75 µM KH2PO4.
Interestingly, the ino2∆ and ino4∆ mutants grew similarly to wild type in GPI, whether
inositol was supplied or not (Figure 13), indicating that GPI was able to be the sole
phosphate and sole inositol source for ino2∆ and ino4∆ strains.
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Figure 9. Northern blot analysis of GIT1 expression in wild type, ino2∆, ino4∆, pho2∆, pho4∆, and
git1∆ strains. Media contain (I+) or lack (I-) 75 µM inositol and contain 0.2 mM (low Pi) or 10
mM (high Pi) inorganic phosphate. Cells were harvested in the logarithmic phase, and Northern
analysis was performed with digoxigenin-labeled probes for GIT1 and control (U3) transcripts as
described in Material and Methods.
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Figure 10-A. TLC plate assay for showing GIT1 promoter during CAT activity in a wild type
strain. Strains grown in medium containing 75 µM inositol and 10 mM KH2PO4 were harvested
and reinoculated into media lacking inositol (I-), containing 5 µM inositol (5I-), or 75 µM inositol
(I+), with either 0.3 mM (low Pi) or 10 mM (high Pi) KH2PO4. GIT1 promoter-driven CAT
activity were measured at the indicated times as described in Material and Methods. Lower
points are substrate and upper points are products. +CTL represents positive control and – CTL
represents negative control. No product is detectable when wild type is grown in +I, high Pi
medium.
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Figure 10-B. GIT1 promoter-driven CAT assay in WT.
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Figure 10-C. GIT1 promoter-driven CAT assay in ino2∆.
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Figure 10-D. GIT1 promoter-driven CAT assay in ino4∆.
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Figure 10-E. GIT1 promoter-driven CAT assay in pho2∆.
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Figure 10-F. GIT1 promoter-driven CAT assay in pho4∆.
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Figure 11. Derepression of GIT1 promoter activity. Strains grown in medium containing 75
µM inositol and 10 mM KH2PO4 were harvested and reinoculated into media lacking
inositol (I-), containing 5 µM inositol (5I-), or 75 µM inositol (I+), with either 0.3 mM (L) or
10 mM (h) KH2PO4. GIT1promoter-driven CAT activity and growth were measured as
described in Material and Methods. Raw data is presented in Figure 10 A-E.
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Figure 12. GIT1 promoter analysis. Plasmids bearing the indicated regions of the promoter fused
to the cat reporter gene were used to transform a wild type Saccharomyces cerevisiae strain. The
location of potential Pho4p (filled box) and Pho2p (empty box) binding sites are depicted. Wild
type cells grown in media lacking (-I) or containing (+I) 75 µM inositol and containing 0.2 mM
(low Pi) or 10 mM (high Pi) KH2PO4 were harvested in logarithmic phase and assayed for CAT
activity.
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Figure 13. GPI as phosphate source. Strains grown in - I, low Pi medium were harvested and
suspended to equivalent OD’s in sterile water. Three 10-fold serial dilutions were made for each
cell suspension. Each cell suspension (5 µl) was spotted onto plates lacking (-I) or containing (+I)
75 µM inositol, containing no source of phosphate (no Pi), containing 75 µM KH2PO4 (KH2PO4)
or containing 75 µM GPI (GPI).
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Table 2
Strains bearing deletions in OPI1, SOK2, and PHD1

* Strains grown in medium containing 75 µM inositol and 10 mM KH2PO4 were harvested and
reinoculated into media lacking inositol (I-), containing 5 µM inositol (5I-), or 75 µM inositol (I+),
with either 0.2 mM (low Pi) or 10 mM (high Pi) KH2PO4. a. Cells were harvested at low OD (0.5~0.9).
b. Cells were harvest at high OD (1.4~1.9). GIT1 promoter-driven CAT was measured as described in
Material and Methods.
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Discussion
Yeast strains have evolved to be responsive to changing environmental and
nutritional conditions (80). The transcriptional machinery deployed in response to these
changes are different and are triggered by specific sensors able to monitor extracellular or
intracellular levels of substrates and affect the expression of genes accordingly (80,81).
Elegant schemes for these regulatory mechanisms have been drawn from thorough
biochemical and genetic analyses of glucose, amino acid, and phosphate utilization, to
name only a few (80). Eukaryotic genes are subject to multiple levels of regulation. My
thesis focuses on the regulation of GIT1 transcription in response to nutritional factors.
In this study, I monitored the effect of phosphate and inositol availability in
regulating GIT1 transcription. My results indicate that signals of phosphate limitation and
inositol limitation induce different but overlapping regulatory programs with regard to
GIT1 expression. Northern blot analysis of a wild-type strain (Figure 9) showed that the
GIT1 transcript was most highly expressed under conditions in which both inositol and
phosphate were limiting. A lower level of GIT1 expression also occurred in media in
which phosphate was limiting but inositol was not (Figure 9). In agreement with the
results of the Northern blot analysis, the wild-type strain exhibited the most GIT1
promoter-driven CAT activity when incubated in media limited for both inositol and
phosphate (Figure 11a). However, GIT1 promoter driven CAT activity was found to be
quite similar when cells were grown in either - I, low Pi or +I, low Pi media (Figure 11a).
A possible explanation for the difference in the results obtained from Northern analysis
versus CAT activity is that the GIT1 message is less stable in +I, low Pi medium, than in
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-I, low Pi medium, whereas CAT activity is not dependent upon the stability of the GIT1
message.
An important aspect of this study was the analysis of the role of the transcription
factors Ino2p, Ino4p, Pho2p, and Pho4p in regulating GIT1 transcription. Northern
blotting experiments showed that when the medium contains inositol in low phosphate
medium, INO2 and INO4 are not required for the induction of GIT1 transcript
accumulation, however, INO2 and INO4 are required when inositol limitation is
combined with phosphate limitation (Figure 9). The induction of CAT activity exhibited
by ino2∆ and ino4∆ in +I, low Pi conditions is similar to that seen in the wild type strain.
With regard to the ino2∆ and ino4∆ mutants, the results obtained through Northern blot
analysis and through measurement of GIT1 promoter-driven CAT activity were quite
similar. In contrast, GIT1 was not transcribed in pho2∆ and pho4∆ under ± I, low Pi, or ±
I, high Pi media (Figure 9).
These results indicate that
PHO2

and

PHO4

are

required for GIT1 transcript
accumulation
conditions

under
tested.

all
Six

regulatory network motifs

Figure 14. The regulatory network consisting of the
transcription factors encoded by INO2, INO4, PHO2, and
PHO4 acting upon the GIT1 promoter might belong to multiinput motif.

were proposed by Lee (17)
et al. The regulatory network
consisting

of

the

transcription factors encoded by INO2, INO4, PHO2, PHO4 acting upon the GIT1
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promoter may belong to multi-input motif (Figure 14), based upon the limited
experiments reported here. However, I have not examined the interactions between
transcription factors, so other model may prove to be more accurate upon further
experimental examination.
Strains bearing deletions in the transcription factors encoding genes OPI1, PHD1,
and SOK2 were also analyzed. The OPI1 gene product is required for repression of
phospholipid biosynthetic gene expression in response to inositol and choline
supplementation (Table 2) (25). Upon transfer of cells to low phosphate medium, the
opi1∆ mutant was found to induce CAT activity earlier than did the wild-type strain
(Table 2). This may indicate that Opi1p plays a role as a negative regulator of GIT1
transcription, but these results need to be verified.
Strains bearing deletions in PHD1 and SOK2 were analyzed because a genome
wide chromatin immunoprecipitation study found binding of Phd1p and Sok2p to the
GIT1 promoter(21). The phd1∆/phd1∆ and sok2∆/sok2∆ strains exhibited GIT1
promoter-driven CAT activity similar to that of the wild type diploid strain. Thus Phd1p
and Sok2p do not appear to be involved in the transcriptional regulation of GIT1 in
response to inositol and phosphate limitation.
The promoter analysis data presented the relationship between potential Pho2p
and Pho4p binding sites and GIT1 gene regulation. The GIT1 promoter region (Figure 12)
contains three potential Pho4p (CACGTK) and two Pho2p (TAATRA/TAANTAA)
binding sites (71). When a DNA sequence containing one potential Pho4p binding site (881 and -639) was deleted, the GIT1 promoter-driven CAT activity slightly decreased
under the four conditions tested (Figure 12). When a DNA sequence containing three
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potential Pho4p binding sites (-640 and -330 relative to the start codon) was removed,
transcript induction was abolished in response to phosphate limitation in both the
presence and absence of inositol (Figure 12). Pho4p, like Ino2p and Ino4p, are bHLH
binding proteins. The GIT1 promoter does not contain a copy of the UASINO2 core
consensus sequence (CATGTG), but does contain a bHLH consensus sequence
(CACGTG) to which Ino2p and Ino4p have been shown to bind to minimally activate
INO1 transcription (56). Some bHLH binding proteins are known to form multiple dimer
combinations that act upon diverse sets of genes (55). Indeed, Ino4p has been shown by
yeast 2-hybrid assay and biochemical assay to interact with Pho4p (55). Thus, it is
tempting to speculate that Pho4p may heterodimerize with Ino2p or Ino4p to activate
GIT1 transcription. The actual mechanism of regulation, however, must be more complex,
as neither Ino2p nor Ino4p is required for transcript accumulation in cells grown in
inositol-containing medium. All four transcription factors are required when cells are
grown in - I, low Pi medium. Clearly, further studies are required to elucidate the details
of GIT1 transcriptional regulation and to demonstrate a direct interaction between Pho4p
or any of the other DNA-binding proteins, and the GIT1 promoter.
In addition to how the transcription factors regulate the GIT1 gene, our study
revealed that GPI can act as the sole phosphate source via a mechanism that requires
Git1p. In fact, there is no discernable difference in growth when the wild type strain is
supplied with 75 µM GPI as compared with 75 µM KH2PO4. To our knowledge, this is
the first demonstration of a phosphate containing organic molecule (GPI) acting as a sole
phosphate source for a eukaryotic cell. GPI was reported to act as sole inositol source in a
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previous study (46). For the inositol auxotrophic strains ino2∆ and ino4∆, GPI acts as the
sole source of both inositol and phosphate.
S. cerevisiae can hydrolyze external phosphatidylinositol to release GPI by
phospholipase B (24). Thus, the combination of external phospholipases and Git1p
provides yeast with the capability of obtaining crucial nutrients (inositol and phosphate)
from environments in which PI, or its deacylation product, GPI, are available. Once
inside the cells, GPI must be metabolized in order to liberate inositol and phosphate
(Figure

7).

The

gene

products

involved

likely

include

one

or

more

glycerophosphodiesterases and glycerol phosphatases. The genes and enzymatic activities
responsible for this metabolism have yet to be determined.
In conclusion, these studies provide a better understanding of the role of
phosphate and inositol in regulating GIT1 transcription. PHO2 and PHO4 are
demonstrated to be required for GIT1 transcription in any condition. Dissection of GIT1
promoter indicates that the Pho4p binding sites are required for GIT1 transcription.
Finally, the study reveals that GPI can be the sole source of both inositol and phosphate
for auxotrophic strains.

Future Studies
Further studies are required to determine whether Ino2p, Ino4p, Pho2p, and Pho4p
bind

directly

to

the

GIT1

promoter.

Mobility

shift

assays

or

chromatin

immunoprecipitation assays could be used for these studies. It will also be important to
determine the mRNA half-life of GIT1 under different nutritional conditions. These
experiments could be performed by measureing GIT1 transcript abundance under
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different nutritional conditions, following the additioin of a transcriptional inhibitor, such
as thiolutin or phenanthroline.
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Appendix I – Medium

Solid Medium
1. YPD
•

1 liter dH2O

•

20 g glucose (=dextrose)

•

10 g yeast extract

•

20 g bacto peptone

•

20 g agar

2. –leu, + I
•

1 liter dH2O

•

20 g glucose (=dextrose)

•

1.7 g YNB salts (Dr. Patton-Vogt Lab synthetic mix)

•

1.0 ml of 2.0 mg/ml trace components

•

5.0 g ammonium sulfate

•

10 ml inositol-free vitamin stock solution (100x)

•

7.5 ml inositol stock solution

•

100 ml of S. cerevisiae 10x leu drop-out solution

•

20 g agar

3. LB-Amp (Luria-Bertani – Ampicillin)
•

1 liter H2O

•

20 g Luria Bertani powder

•

4 ml Ampicillin (250x)

•

20 g agar

Liquid Medium
1. YPD
•

1 liter dH2O

•

20 g glucose (=dextrose)

•

10 g yeast extract
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•

20g bacto peptone

2. - I, low/high Pi
•

1 liter dH2O

•

30 g glucose (=dextrose)

•

1.74 g of Phosphate free YNB salts (Dr. Patton-Vogt lab synthetic mix)

•

1.0 ml of 2.0 mg/ml liquid solution of Trace Components

•

5.0 g ammonium sulfate

•

10 ml inositol-free vitamin stock solution (100x)

•

20 ml of S. cerevisiae Complete amino-acid solution

•

200 µl KH2PO4 stock solution (1M) – low Pi or

•

10 ml KH2PO4 stock solution (1M) – high Pi

3. + I, low/high Pi
•

1 liter dH2O

•

30 g glucose (=dextrose)

•

1.74 g of Phosphate free YNB salts (Dr. Patton-Vogt lab synthetic mix)

•

1.0 ml of 2.0 mg/ml liquid solution of Trace Components

•

5.0 g ammonium sulfate

•

10 ml inositol-free vitamin stock solution (100x)

•

20 ml of S. cerevisiae Complete amino-acid solution

•

750 µl inositol stock solution (100mM)

•

200 µl KH2PO4 stock solution (1M) – low Pi or

•

10 ml KH2PO4 stock solution (1M) – high Pi

4. - I, low/high Pi, -leu
•

1 liter dH2O

•

30 g glucose (=dextrose)

•

1.74 g of Phosphate free YNB salts (Dr. Patton-Vogt lab synthetic mix)

•

1.0 ml of 2.0 mg/ml liquid solution of Trace Components

•

5.0 g ammonium sulfate

•

10 ml inositol-free vitamin stock solution (100x)

•

100 ml of S. cerevisiae 10x leu drop-outsolution
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•

200 µl KH2PO4 stock solution (1M) – low Pi or

•

10 ml KH2PO4 stock solution (1M) – high Pi

5. + I, low/high Pi, -leu
•

1 liter dH2O

•

30 g glucose (=dextrose)

•

1.74 g of Phosphate free YNB salts (Dr. Patton-Vogt lab synthetic mix)

•

1.0 ml of 2.0 mg/ml liquid solution of Trace Components

•

5.0 g ammonium sulfate

•

10 ml inositol-free vitamin stock solution (100x)

•

100 ml of S. cerevisiae 10x leu drop-out solution

•

750 µl inositol stock solution (100mM)

•

200 µl KH2PO4 stock solution (1M) – low Pi or

•

10 ml KH2PO4 stock solution (1M) – high Pi

6. LB-amp (Luria-Bertani – Ampicillin)
•

1 liter H2O

•

20g Luria Bertani powder

•

4 ml Ampicillin (250x)

7. Trace components (1000x)
•

5.0 g boric acid

•

0.4 g cupric sulfate

•

1.0 g potassium iodide

•

2.0 g ferric chloride

•

4.0 g manganese sulfate

•

2.0 g sodium molybdate

•

4.0 g zinc sulfate

Note: The components should be mixed with a mortar and pestle. Dissolve 2
mg/ml in dH2O and store at 40C.
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